FDA Reopening Comment Period on the Cosmetics and Foods Portions of its Guidance on Determining if Human Research Studies Require an Investigational New Drug Application

CFSAN Constituent Update

February 5, 2014 

FDA is reopening, for 60 days, the comment period for specific portions of its final guidance for clinical investigators, sponsors, and institutional review boards (IRBs), entitled “Investigational New Drug Applications (INDs) -- Determining Whether Human Research Studies Can Be Conducted Without an IND,” which was announced in the September 10, 2013 Federal Register. The comment period is reopening only for subsections of the final guidance that address the applicability of the IND regulations to clinical research studies involving cosmetics and foods (including dietary supplements). The Agency is taking this action in response to requests that it provide an additional opportunity to submit comments on these portions of the guidance.

Additional Information:

Page Last Updated: 06/06/2014
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English